Early PrimeC treatment extended ALS patient survival >14 months and reduced death risk by 65% versus delayed treatment.
Promising results emerging: https://bit.ly/4scGmkZ
Early treatment with PrimeC was linked to longer survival in people with ALS compared with delayed treatment, based on long term data.
#ALSResearch #ALSAwareness #HopeInResearch #Bionews #ALSNewsToday